Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...

In letter, senators say recent staff firings could affect drug and device approval, food safety and public health threats.

SWTX reports mixed fourth-quarter 2024 results. Its newly approved desmoid tumor drug, Ogsiveo, witnesses a strong launch.

By selling its China business to AstraZeneca, FibroGen can focus on developing a prostate cancer drug and potentially ...

The United States on Friday proposed a draft United Nations resolution to mark the third anniversary of Russia's invasion of ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...

Bristol-Myers Squibb released financial results for Q4 2024. Check out why I am upgrading BMY stock's rating from 'Buy' to ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, ...

Hany Elmariah, MD, discussed the safety profile of fedratinib and its evolving role in the post-transplant setting for patients with myeloproliferative neoplasms.

Head lice affect millions of children every year. Schoolchildren are commonly affected by head lice, which attach to hair and ...